"Leica" Bond Ready-to-Use Primary Antibody CD138 (MI15)(Non-Sterile) - Taiwan Registration c89aefec4e483f19dc87ea1e7a936b71

Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody CD138 (MI15)(Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number c89aefec4e483f19dc87ea1e7a936b71 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.